Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, underscore a shift to ...

Dec 12 (Reuters) - Alzheimer's trials testing Novo Nordisk’s blockbuster GLP-1 drug semaglutide, despite their failure, ...

Despite reported slowing of progression, regulators said the evidence on the novel oral agent blarcamesine did not support a ...

Microglial activity appears to determine when amyloid becomes biologically significant, reshaping how clinicians interpret ...

Alzheimer’s disease has long resisted simple answers, yet a growing body of research is pointing to an unexpected ally ...

Zahydie Burgos's parents moved into the home she shares with her husband after he was diagnosed with Alzheimer's disease at ...

Tel Aviv: Israeli and Dutch researchers have unveiled a new technique that allows scientists to precisely measure toxic ...

New research shows that blood from older animals can speed up Alzheimer’s-related changes in the brain, while young blood may ...

Researchers at UCLA have developed an artificial intelligence tool that can use electronic health records to identify ...

Alzheimer's disease is the most common form of dementia worldwide and continues to be one of the greatest public health ...

The Rutgers Krieger Klein Alzheimer's Research Center has received a $1.5 million philanthropic gift from the Norman and Mary ...

It is widely known that Alzheimer's disease is mainly associated with the overproduction of β-amyloid peptides and damage ...